News: National Breast Cancer Foundation
Switching off “jumping genes” to outsmart resistant breast cancer
Breast cancer is the most commonly diagnosed cancer among women in Australia, with more than 21,000 new cases each year. Around 70 per cent of these cancers are oestrogen receptor–positive (ER+), a type that often responds well to hormone-based treatments.
[Read more about Switching off “jumping genes” to outsmart resistant breast cancer]
SAiGENCI researcher awarded funding for breast cancer research
Dr Joanna Achinger-Kawecka has been awarded a National Breast Cancer Foundation (NBCF) 2025 Research Project Grant, providing essential support for investigator-initiated research projects which are critical to building Australia's breast cancer research pipeline and addressing critical research questions.
[Read more about SAiGENCI researcher awarded funding for breast cancer research]
